PEAK6 Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-27,903
Closed -$814K 3952
2024
Q2
$781K Sell
27,903
-8,031
-22% -$221K ﹤0.01% 1992
2024
Q1
$997K Sell
35,934
-39,351
-52% -$1.09M ﹤0.01% 1936
2023
Q4
$2.17M Buy
75,285
+51,630
+218% +$1.56M 0.01% 1456
2023
Q3
$785K Sell
23,655
-9,568
-29% -$338K ﹤0.01% 2016
2023
Q2
$1.22M Buy
33,223
+16,238
+96% +$632K 0.01% 1574
2023
Q1
$693K Buy
+16,985
New +$734K ﹤0.01% 2128
2022
Q4
Sell
-63,512
Closed -$3.04M 5031
2022
Q3
$2.78M Buy
63,512
+30,289
+91% +$1.47M 0.01% 1274
2022
Q2
$1.22M Sell
33,223
-127,185
-79% -$6.48M ﹤0.01% 2877
2022
Q1
$8.3M Buy
+160,408
New +$8.32M 0.02% 788
2021
Q3
Sell
-47,620
Closed -$2.11M 5620
2021
Q2
$1.86M Sell
47,620
-72,359
-60% -$2.81M ﹤0.01% 1963
2021
Q1
$4.35M Buy
119,979
+29,373
+32% +$1.04M 0.01% 1170
2020
Q4
$3.33M Sell
90,606
-35,477
-28% -$1.3M 0.01% 1410
2020
Q3
$4.39M Buy
126,083
+34,905
+38% +$1.22M 0.01% 1045
2020
Q2
$2.83M Sell
91,178
-223,401
-71% -$7.59M 0.01% 1204
2020
Q1
$9.74M Buy
314,579
+238,522
+314% +$8.13M 0.06% 316
2019
Q4
$2.83M Buy
76,057
+65,759
+639% +$2.34M 0.01% 893
2019
Q3
$351K Sell
10,298
-5,684
-36% -$207K ﹤0.01% 2539
2019
Q2
$657K Sell
15,982
-29,152
-65% -$1.16M ﹤0.01% 2079
2019
Q1
$1.82M Buy
+45,134
New +$1.81M 0.01% 1373

Other funds holding PFE

PEAK6 Investments's PFE Position: Q3 2024 in Review

PEAK6 Investments sold out of Pfizer (PFE) in Q3 2024, closing a stake of 27,903 shares — an estimated $814K sold.

PEAK6 Investments first reported a position in PFE in Q1 2019 and held it in 19 quarters. The position peaked at $9.74M in Q1 2020. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • PEAK6 Investments reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 27,903 Pfizer shares in Q3 2024, an estimated $814K.
  • PEAK6 Investments first reported a position in Pfizer in Q1 2019 and held it in 19 quarters.
  • PEAK6 Investments's Pfizer position peaked at $9.74M in Q1 2020.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.